Background Lithium is a first-line treatment in bipolar disorder, but individual response is
variable. Previous studies have suggested that lithium response is a heritable trait. However, …

Bipolar disorder (BD) is a common and highly heritable mental illness and genome-wide
association studies (GWAS) have robustly identified the first common genetic variants involved …

We conducted a genome-wide association study (GWAS) and a follow-up study of bipolar
disorder (BD), a common neuropsychiatric disorder. In the GWAS, we investigated 499,494 …

Background Suicide is a leading cause of death worldwide, and nonfatal suicide attempts,
which occur far more frequently, are a major source of disability and social and economic …

Bipolar disorder (BD) is a genetically complex mental illness characterized by severe
oscillations of mood and behaviour. Genome-wide association studies (GWAS) have identified …

Objective: More than 90% of people who attempt suicide have a psychiatric diagnosis;
however, twin and family studies suggest that the genetic etiology of suicide attempt is partially …

Objective The assessment of response to lithium maintenance treatment in bipolar disorder (BD)
is complicated by variable length of treatment, unpredictable clinical course, and often …

Objective: The course and clinical predictors of rehospitalization were studied in a large
sample of adolescent patients with anorexia nervosa who had been treated at five European …

Objective: Suicidal behavior is heritable and is a major cause of death worldwide. Two large-scale
genome-wide association studies (GWASs) recently discovered and cross-validated …

Importance Lithium is a first-line mood stabilizer for the treatment of bipolar affective disorder
(BPAD). However, the efficacy of lithium varies widely, with a nonresponse rate of up to 30%…